SCHEMBL3209356

SCHEMBL3209356

CC1=C(C)C(C)=C(c2ccc3ccccc3c2CO)C1

nearest known ligand 0.37

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
HSD17B10 Q99714 3/20 0.37
CYP1A2 P05177 2/20 0.37
CYP2C9 P11712 1/20 0.37
CYP2C19 P33261 1/20 0.37
KDM4E B2RXH2 6/20 0.36
MAPT P10636 5/20 0.36
TDP1 Q9NUW8 3/20 0.36
ALDH1A1 P00352 6/20 0.35
GAA P10253 5/20 0.35
TAAR1 Q96RJ0 1/20 0.35
NOTUM Q6P988 1/20 0.35
KMT2A Q03164 5/20 0.33
MEN1 O00255 2/20 0.33
CRHBP P24387 1/20 0.33
CRHR2 Q13324 1/20 0.33
GLA P06280 1/20 0.33
HPGD P15428 1/20 0.33
CYP2A6 P11509 2/20 0.33
TSHR P16473 2/20 0.33
LMNA P02545 1/20 0.32

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL3199015 0.81 DNMT1 (0.35) CYP2C9CYP2C19MAPTALDH1A1KMT2A
Hydrochloric Acid SCHEMBL3208521 0.81 MEN1 (0.30) HSD17B10CYP1A2CYP2C9CYP2C19KDM4E
SCHEMBL3206277 0.80 KMT2A (0.35) HSD17B10CYP1A2CYP2C9CYP2C19KDM4E
SCHEMBL3210917 0.80 ALDH1A1 (0.41) HSD17B10CYP1A2CYP2C9CYP2C19KDM4E
SCHEMBL3211646 0.78 HSD17B10 (0.36) HSD17B10CYP1A2CYP2C9CYP2C19KDM4E
SCHEMBL3191003 0.78 HSD17B10 (0.36) HSD17B10CYP1A2CYP2C9CYP2C19KDM4E
Hydrochloric Acid SCHEMBL3259849 0.77
Hydrochloric Acid SCHEMBL3263819 0.77 KDM4E (0.33) KDM4EMAPTTDP1
SCHEMBL3199381 0.77 SLC2A1 (0.38) HSD17B10CYP1A2CYP2C9CYP2C19KMT2A
Hydrochloric Acid SCHEMBL3263821 0.77

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 8 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-7732643-B2 Transition metal complex, catalyst for olefin polymerization, and process for producing olefin polymer with the same SUMITOMO CHEMICAL COMPANY, LIMITED (JP) 2010-06-08 US disclosed
US-7671226-B2 Transition metal complex, catalyst for olefin polymerization, and process for producing olefin polymer with the same SUMITOMO CHEMICAL COMPANY, LIMITED (JP) 2010-03-02 US disclosed
US-20100048933-A1 TRANSITION METAL COMPLEX, CATALYST FOR OLEFIN POLYMERIZATION, AND PROCESS FOR PRODUCING OLEFIN POLYMER WITH THE SAME HANAOKA HIDENORI 2010-02-25 US disclosed
EP-1426379-B1 TRANSITION METAL COMPLEX,CATALYST FOR OLEFIN POLYMERIZATION, AND PROCESS FOR PRODUCING OLEFIN POLYMER WITH THE SAME SUMITOMO CHEMICAL CO (JP) 2009-11-11 EP disclosed
US-20090054607-A1 Transition metal complex, catalyst for olefin polymerization, and process for producing olefin polymer with the same HANAOKA HIDENORI 2009-02-26 US disclosed
US-7439379-B2 Transition metal complex, catalyst for olefin polymerization, and process for producing olefin polymer with the same SUMITOMO CHEMICAL CO., LTD. (JP) 2008-10-21 US disclosed
US-20040242410-A1 Transition metal complex, catalyst for olefin polymerization, and process for producing olefin polymer with the same SUMITOMO CHEMICAL COMPANY, LIMITED (JP) 2004-12-02 US disclosed
EP-1426379-A1 TRANSITION METAL COMPLEX,CATALYST FOR OLEFIN POLYMERIZATION, AND PROCESS FOR PRODUCING OLEFIN POLYMER WITH THE SAME Sumitomo Chemical Company, Limited (JP) 2004-06-09 EP disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20090054607-A1 Transition metal complex, catalyst for olefin polymerization, and process for producing olefin polymer with the same C1R, C1S, AP1M1 HSD17B10 274/4885CYP1A2 315/4885CYP2C9 1113/4885
US-20100048933-A1 TRANSITION METAL COMPLEX, CATALYST FOR OLEFIN POLYMERIZATION, AND PROCESS FOR PRODUCING OLEFIN POLYMER WITH THE SAME C1R, C1S, AP1M1 HSD17B10 274/4885CYP1A2 315/4885CYP2C9 1113/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.